当前位置: 首页 > 详情页

The influence of anthracosis and p16(ink4a) gene aberrant methylation on small-sized pulmonary adenocarcinoma

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [a]Center of Clinical Pathology, China Capital Medical University, Beijing, China [b]Department of Pathology, Xuanwu Hospital of China Capital Medical University, Beijing, China [c]Department of Pathology, Beijing Tongren affiliated Hospital of China Capital Medical University, Beijing, China
出处:
ISSN:

关键词: Anthracosis p16(ink4a) gene Aberrant methylation Small-sized pulmonary adenocarcinoma

摘要:
Aims: Anthracosis is the deposition of black dusty material in the pulmonary parenchyma. Previous reports showed anthracosis and p16(ink4a) gene aberrant methylation are closely related to the promotion and progression of small-sized pulmonary adenocarcinoma. In this study, we investigated the influence of anthracosis and p16(ink4a) gene aberrant methylation on clinical samples from patients with small-sized adenocarcinoma. Methods and results: DNA was bisulfite modified and methylation-specific PCR was performed to detect p16(ink4a) gene aberrant methylation; black dusty material was extracted from lung tissues. Anthracotic index (AI) was defined as the absolute absorbance by densitometry. The histopathological diagnosis was concluded according to Noguchi's classification for small-sized pulmonary adenocarcinoma. The mean AI and the frequency of p16(ink4a) gene aberrant methylation of heavy smokers were significantly higher than that of nonsmokers ( <0.01 and <0.05, respectively). The frequency of p16(ink4a) gene aberrant methylation of early stage small-sized adenocarcinoma was lower than that of advanced and poorly differentiated, while p16(ink4a) protein expression level of early stage small-sized adenocarcinoma was significantly higher than that of poorly differentiated small-sized adenocarcinoma (P<0.05). Conclusions: AI and p16(ink4a) gene aberrant methylation may provide a potential universal biomarker for small-sized adenocarcinoma. (C) 2010 Elsevier Inc. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2010]版:
大类 | 4 区 医学
小类 | 4 区 病理学
最新[2025]版:
大类 | 4 区 医学
小类 | 3 区 病理学
JCR分区:
出版当年[2009]版:
Q2 PATHOLOGY
最新[2023]版:
Q2 PATHOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2009版] 出版当年五年平均 出版前一年[2008版] 出版后一年[2010版]

第一作者:
第一作者机构: [a]Center of Clinical Pathology, China Capital Medical University, Beijing, China [*]Center of Clinical Pathology, China Capital Medical University, No.10 Xitoutiao, You An Men street, Beijing 100069, P.R. China.
通讯作者:
通讯机构: [*]Center of Clinical Pathology, China Capital Medical University, No.10 Xitoutiao, You An Men street, Beijing 100069, P.R. China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:17069 今日访问量:2 总访问量:918 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院